STEPHANIE CLEVELAND: Open Payments
NPI 1053358283 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,103 in 53 payments from 16 companies in 2025. Trend: 2023 $1,208 · 2024 $1,317 · 2025 $2,103
Food & beverage: $1,224Travel & lodging: $879
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 3 | $879 |
| E.R. Squibb & Sons, L.L.C. | 11 | $195 |
| Alnylam Pharmaceuticals Inc. | 12 | $182 |
| Abbott Laboratories | 1 | $173 |
| Amgen Inc. | 3 | $127 |
| Actelion Pharmaceuticals US, Inc. | 5 | $115 |
| AstraZeneca Pharmaceuticals LP | 2 | $95 |
| BridgeBio Pharma, Inc. | 2 | $66 |
| PFIZER INC. | 3 | $53 |
| Insulet Corporation | 1 | $43 |
Products named: Barostim Neo System, CAMZYOS, AMVUTTRA, MITRACLIP, REPATHA, UPTRAVI, LOKELMA, Attruby.
Industry payments across AL — which companies pay providers there.
